🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II, open-label, single-arm study investigating the combin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-30
Trial ID
NCT06757387
Treatments Being Tested
This is a prospective, multicenter, open-label, phase Ib/II clinical study ...
Status
Recruiting
Location
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Start Date
2025-08-27
Trial ID
NCT07093710
Treatments Being Tested
This is a phase 3, open-label, randomized, multinational study to evaluate ...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2024-05-13
Trial ID
NCT07234162
Treatments Being Tested
This is a prospective, multicenter, open-label, phase Ib/II clinical study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07339527
Treatments Being Tested
This is a phase I/II study evaluate the safety and efficacy targeted agents...
Status
Not Yet Recruiting
Location
Ruijin Hospital
Start Date
2026-07
Trial ID
NCT07706959
Natural killer/T-cell lymphoma (nasal type) is a mature T/NK-cell lymphoma ...
Status
Recruiting
Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Start Date
2026-03
Trial ID
NCT07380984
Treatments Being Tested
In decades, the outcome of patients with peripherial T-cell lymphomas is di...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-15
Trial ID
NCT07081607
Treatments Being Tested
This is a prospective, single-center phase I/II study, with the purpose of ...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-08-26
Trial ID
NCT07754890
Treatments Being Tested
This is a randomized, open-label, multicenter Phase III study evaluating th...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2026-07-30
Trial ID
NCT07639879
Treatments Being Tested